Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;89(2):599-601.
doi: 10.1111/bcp.15596. Epub 2022 Dec 5.

Fomepizole should not be used more liberally in paracetamol overdose

James W Dear  1
Affiliations

Fomepizole should not be used more liberally in paracetamol overdose

James W Dear. Br J Clin Pharmacol. 2023 Feb.

Abstract

Fomepizole is a promising new treatment for preventing liver injury following paracetamol (acetaminophen) overdose. However, we need robust clinical trials to be performed to demonstrate its effect on clinical outcomes that are important to our patients and important to healthcare providers. Until such trials are performed, the toxicology community should learn the lessons from the COVID pandemic-potential novel therapeutic options may be theoretically appealing, but their effectiveness needs to be assessed in robust clinical trials before they are used in clinical practice.

Keywords: acetaminophen; fomepizole; overdose; paracetamol.

PubMed Disclaimer

Conflict of interest statement

J.W.D. was the Chief Investigator on the POP Trial of calmangafodipir in paracetamol overdose.

References

    1. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019‐nCoV) in vitro. Cell Res. 2020;30(3):269‐271. doi:10.1038/s41422-020-0282-0 - DOI - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016/j.ijantimicag.2020.105949 - DOI - PMC - PubMed
    1. Niburski K, Niburski O. Impact of Trump's promotion of unproven COVID‐19 treatments and subsequent Internet trends: observational study. J Med Internet Res. 2020;22(11):e20044. doi:10.2196/20044 - DOI - PMC - PubMed
    1. Group RC , Horby P, Mafham M, et al. Effect of hydroxychloroquine in hospitalized patients with Covid‐19. N Engl J Med. 2020;383(21):2030‐2040. doi:10.1056/NEJMoa2022926 - DOI - PMC - PubMed
    1. Axfors C, Schmitt AM, Janiaud P, et al. Mortality outcomes with hydroxychloroquine and chloroquine in COVID‐19 from an international collaborative meta‐analysis of randomized trials. Nat Commun. 2021;12(1):2349. doi:10.1038/s41467-021-22446-z - DOI - PMC - PubMed

MeSH terms